FDA Inspection
Bristol-Myers Squibb Holdings Pharma Ltd. Liability CompanyBristol-Myers Squibb Holdings Pharma Ltd. Liability Company – FDA Inspection, Sep 11, 2017
Record Details
This FDA Inspection record concerns Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company, with an inspection on September 11, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- September 11, 2017
- Product Type
- Drugs
View Company Profile
ID · 1650c515-0cbd-4eb9-82f5-f588c5791f89
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1030016
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company
13| Date | Classification | Office | Project area |
|---|---|---|---|
| February 13, 2026 | Not classified | San Juan District Office | |
| June 6, 2024 | Not classified | San Juan District Office | |
| July 12, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 19, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 6, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.